Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
FLNA
$0.48
+6.92%
FLNA
· Filana Therapeutics, Inc.
Market Cap
$22.52M
Shares
50.27M
Volume · Nov 12
432.53K
Avg daily vol (3M)
2.01M
All webcasts
Earnings call · FY2026 Q1
Filana Therapeutics, Inc. (FLNA) Q1 2026 Earnings Call
Net income
-$10.33M
Forward guidance
2 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed May 7, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Cash
at June 30, 2026
|
$47M – $50M | — | |
|
Net cash used in operations
first-half 2026
|
$14M – $17M | — |
SEC filing · Item 2.02
8-K earnings release
Filed May 7, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed May 7, 2026 · complete as-filed document